Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alphonsus C. M. van den Bergh"'
Autor:
Bradley R. Pieters, Fernanda G. Herrera, Antoine Engelen, Philippe Maingon, Santhanam Sundar, Christopher D Scrase, John Armstrong, Alphonsus C. M. van den Bergh, Ana Boladeras, Elzbieta van der Steen-Banasik, Michel Bolla, Amit Bahl, Laurence Collette, Christian Carrie, Joe M O'Sullivan, Demetrios Andreopoulos, Jihane Boustani, Annerie Slot, Anouk Neven, Jan Jansa, David Azria, Karine Peignaux-Casasnovas
Publikováno v:
Journal of clinical oncology, vol. 39, no. 27, pp. 3022-3033
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(27), 3022-3033. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology, 39(27), 3022-3033. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(27), 3022-3033. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology, 39(27), 3022-3033. American Society of Clinical Oncology
PURPOSE The European Organisation for Research and Treatment of Cancer (EORTC) trial 22991 ( NCT00021450 ) showed that 6 months of concomitant and adjuvant androgen suppression (AS) improves event- (EFS, Phoenix) and clinical disease-free survival (D
Autor:
Gijs P A, van den Bergh, Malou C P, Kuppen, Hans M, Westgeest, Niven, Mehra, Winald R, Gerritsen, Katja K H, Aben, Inge M, van Oort, Reindert J A, van Moorselaar, Diederik M, Somford, Alfonsus J M, van den Eertwegh, André M, Bergman, Alphonsus C M, van den Bergh, Carin A, Uyl-de Groot
Publikováno v:
Prostate cancer and prostatic diseases.
The objective of this real-world population study is to investigate incidence and treatment of visceral metastases (VMs) in castration resistant prostate cancer (CRPC) patients and their survival.CRPC-patients in the CAPRI-registry between 2010 and 2
Autor:
Gijs P. A. van den Bergh, Malou C. P. Kuppen, Hans M. Westgeest, Niven Mehra, Winald R. Gerritsen, Katja K. H. Aben, Inge M. van Oort, Reindert J. A. van Moorselaar, Diederik M. Somford, Alfonsus J. M. van den Eertwegh, André M. Bergman, Alphonsus C. M. van den Bergh, Carin A. Uyl-de Groot
Publikováno v:
Prostate Cancer and Prostatic Diseases. Nature Publishing Group
Prostate Cancer and Prostatic Diseases. SPRINGERNATURE
van den Bergh, G P A, Kuppen, M C P, Westgeest, H M, Mehra, N, Gerritsen, W R, Aben, K K H, van Oort, I M, van Moorselaar, R J A, Somford, D M, van den Eertwegh, A J M, Bergman, A M, van den Bergh, A C M & Uyl-de Groot, C A 2022, ' Incidence and survival of castration-resistant prostate cancer patients with visceral metastases : results from the Dutch CAPRI-registry ', Prostate Cancer and Prostatic Diseases . https://doi.org/10.1038/s41391-022-00605-7
Prostate Cancer and Prostatic Diseases, 26, 162-169
Prostate Cancer and Prostatic Diseases, 26, 1, pp. 162-169
Prostate Cancer and Prostatic Diseases, 26(1), 162-169. Nature Publishing Group
Prostate Cancer and Prostatic Diseases. SPRINGERNATURE
van den Bergh, G P A, Kuppen, M C P, Westgeest, H M, Mehra, N, Gerritsen, W R, Aben, K K H, van Oort, I M, van Moorselaar, R J A, Somford, D M, van den Eertwegh, A J M, Bergman, A M, van den Bergh, A C M & Uyl-de Groot, C A 2022, ' Incidence and survival of castration-resistant prostate cancer patients with visceral metastases : results from the Dutch CAPRI-registry ', Prostate Cancer and Prostatic Diseases . https://doi.org/10.1038/s41391-022-00605-7
Prostate Cancer and Prostatic Diseases, 26, 162-169
Prostate Cancer and Prostatic Diseases, 26, 1, pp. 162-169
Prostate Cancer and Prostatic Diseases, 26(1), 162-169. Nature Publishing Group
Item does not contain fulltext BACKGROUND: The objective of this real-world population study is to investigate incidence and treatment of visceral metastases (VMs) in castration resistant prostate cancer (CRPC) patients and their survival. METHODS: C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10dc48f47dba4e295a9d0360105b0f15
https://research.vumc.nl/en/publications/ee0eddda-1952-4024-b869-14b80743ad65
https://research.vumc.nl/en/publications/ee0eddda-1952-4024-b869-14b80743ad65
Autor:
Peter De Brouwer, Ben G. L. Vanneste, Flora E. van Leeuwen, J. Martijn Kerst, Sjoukje Lubberts, Alphonsus C. M. van den Bergh, Tineke J. Smilde, J. Alfred Witjes, Jourik A. Gietema, Berthe M.P. Aleman, Maureen J.B. Aarts, O. W. M. Meijer, Maarten C.C.M. Hulshof, Gerard Groenewegen, Simon Horenblas, Ronald de Wit, Katarzina Jóźwiak, Michael Schaapveld, Luca Incrocci, Hetty A van den Berg, Harmke J. Groot, Alexandra W. van den Belt-Dusebout
Publikováno v:
Groot, H J, Gietema, J A, Aleman, B M P, Incrocci, L, de Wit, R, Witjes, J A, Groenewegen, G, de Brouwer, P, Meijer, O W M, Hulshof, M C C M, van den Berg, H A, Smilde, T J, Vanneste, B G L, Aarts, M J, van den Bergh, A C M, Kerst, J M, van den Belt-Dusebout, A W, Lubberts, S, Jóźwiak, K, Horenblas, S, van Leeuwen, F E & Schaapveld, M 2018, ' Risk of diabetes after para-aortic radiation for testicular cancer ', British Journal of Cancer, vol. 119, no. 7, pp. 901-907 . https://doi.org/10.1038/s41416-018-0248-x
British Journal of Cancer, 119(7), 901-907. Nature Publishing Group
British journal of cancer, 119(7), 901-907. Nature Publishing Group
British Journal of Cancer, 119, 901-907
British Journal of Cancer
British Journal of Cancer, 119, 7, pp. 901-907
British Journal of Cancer, 119(7), 901-907. Nature Publishing Group
British journal of cancer, 119(7), 901-907. Nature Publishing Group
British Journal of Cancer, 119, 901-907
British Journal of Cancer
British Journal of Cancer, 119, 7, pp. 901-907
BACKGROUND: While the risk of diabetes is increased following radiation exposure to the pancreas among childhood cancer survivors, its association among testicular cancer (TC) survivors has not been investigated.METHODS: Diabetes risk was studied in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77e9f1b2251f1104f84fccbd45137d30
https://research.vumc.nl/en/publications/fbc13bdd-0cb2-436b-883c-a0a5c6311c9f
https://research.vumc.nl/en/publications/fbc13bdd-0cb2-436b-883c-a0a5c6311c9f
Autor:
Igor Cordia, Joan van den Bosch, Hans M. Westgeest, Aad I. de Vos, Lidwine W. Tick, Ronald de Wit, Marco B. Polee, Maud M. Geenen, Alphonsus J. M. van den Eertwegh, Frank P. J. Peters, Mathijs P. Hendriks, Roan Spermon, Michiel O. Boerma, Carin A. Uyl-de Groot, Winald R. Gerritsen, Harrie P. Beerlage, Agnes J. van de Wouw, Alphonsus C. M. van den Bergh, Jules L.L.M. Coenen, Monique M.E.M. Bos, Reindert J.A. van Moorselaar, Pieter van den Berg, Haiko J. Bloemendal
Publikováno v:
European Urology Focus, 4(5), 694. Elsevier BV
European Urology Focus, 4, 694-701
European urology focus, 4(5), 694-701. Elsevier BV
European Urology Focus, 4(5), 694-701. Elsevier BV
European Urology, 4(5), 694-701. Elsevier
European Urology Focus, 4, 5, pp. 694-701
Westgeest, H M, Uyl-de Groot, C A, van Moorselaar, R J A, de Wit, R, van den Bergh, A C M, Coenen, J L L M, Beerlage, H P, Hendriks, M P, Bos, M M E M, van den Berg, P, van de Wouw, A J, Spermon, R, Boerma, M O, Geenen, M M, Tick, L W, Polee, M B, Bloemendal, H J, Cordia, I, Peters, F P J, de Vos, A I, van den Bosch, J, van den Eertwegh, A J M & Gerritsen, W R 2018, ' Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer Registry ', European Urology Focus, vol. 4, no. 5, pp. 694-701 . https://doi.org/10.1016/j.euf.2016.09.008
European Urology Focus, 4, 694-701
European urology focus, 4(5), 694-701. Elsevier BV
European Urology Focus, 4(5), 694-701. Elsevier BV
European Urology, 4(5), 694-701. Elsevier
European Urology Focus, 4, 5, pp. 694-701
Westgeest, H M, Uyl-de Groot, C A, van Moorselaar, R J A, de Wit, R, van den Bergh, A C M, Coenen, J L L M, Beerlage, H P, Hendriks, M P, Bos, M M E M, van den Berg, P, van de Wouw, A J, Spermon, R, Boerma, M O, Geenen, M M, Tick, L W, Polee, M B, Bloemendal, H J, Cordia, I, Peters, F P J, de Vos, A I, van den Bosch, J, van den Eertwegh, A J M & Gerritsen, W R 2018, ' Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer Registry ', European Urology Focus, vol. 4, no. 5, pp. 694-701 . https://doi.org/10.1016/j.euf.2016.09.008
Background: Trials in castration-resistant prostate cancer (CRPC) treatment have shown improved outcomes, including survival. However, as trial populations are selected, results may not be representative for the real-world population. The aim of this